Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Yeung

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Pharmacology, Biochemistry, and Behavior|January 3, 2012
The anxiolytic effects of somatostatin following intra-septal and intra-amygdalar microinfusions are reversed by the selective sst2 antagonist PRL2903Michelle Yeung, Dallas Treit
CJEM|May 28, 2022
Facilitated peer mentoring to close the gender gap in academic emergency medicineEugenia Michelle Yeung, Ayesha Zia
Psychopharmacology|March 23, 2011
Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusionsMichelle Yeung, Elif Engin, Dallas Treit
British Journal of Hospital Medicine (London, England : 2005)|October 28, 2008
Isaacs syndromeNeel Sharma, Surabhi Verma, Michelle Yeung
Neuropharmacology|September 25, 2015
Ventral hippocampal histamine increases the frequency of evoked theta rhythm but produces anxiolytic-like effects in the elevated plus mazeMichelle Yeung, Dallas Treit, Clayton T Dickson
Hippocampus|January 3, 2013
Intrahippocampal infusion of the Ih blocker ZD7288 slows evoked theta rhythm and produces anxiolytic-like effects in the elevated plus mazeMichelle Yeung, Clayton T Dickson, Dallas Treit
Neuropharmacology|July 5, 2011
A critical test of the hippocampal theta model of anxiolytic drug actionMichelle Yeung, Dallas Treit, Clayton T Dickson
Frontiers in Pharmacology|November 6, 2023
Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosisHossein Rafiei, Michelle Yeung, Sara Kowalski, et al.
Palliative Care and Social Practice|December 25, 2023
Palliative care, homelessness, and restricted or uncertain immigration statusBriony F Hudson, Elizabeth Dzeng, Angela Burnett, et al.
Neuropharmacology|July 16, 2013
FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal thetaMichelle Yeung, Lily Lu, Adam M Hughes, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pharmacology, Biochemistry, and Behavior|January 3, 2012
The anxiolytic effects of somatostatin following intra-septal and intra-amygdalar microinfusions are reversed by the selective sst2 antagonist PRL2903Michelle Yeung, Dallas Treit
CJEM|May 28, 2022
Facilitated peer mentoring to close the gender gap in academic emergency medicineEugenia Michelle Yeung, Ayesha Zia
Psychopharmacology|March 23, 2011
Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusionsMichelle Yeung, Elif Engin, Dallas Treit
British Journal of Hospital Medicine (London, England : 2005)|October 28, 2008
Isaacs syndromeNeel Sharma, Surabhi Verma, Michelle Yeung
Neuropharmacology|September 25, 2015
Ventral hippocampal histamine increases the frequency of evoked theta rhythm but produces anxiolytic-like effects in the elevated plus mazeMichelle Yeung, Dallas Treit, Clayton T Dickson
Hippocampus|January 3, 2013
Intrahippocampal infusion of the Ih blocker ZD7288 slows evoked theta rhythm and produces anxiolytic-like effects in the elevated plus mazeMichelle Yeung, Clayton T Dickson, Dallas Treit
Neuropharmacology|July 5, 2011
A critical test of the hippocampal theta model of anxiolytic drug actionMichelle Yeung, Dallas Treit, Clayton T Dickson
Frontiers in Pharmacology|November 6, 2023
Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosisHossein Rafiei, Michelle Yeung, Sara Kowalski, et al.
Palliative Care and Social Practice|December 25, 2023
Palliative care, homelessness, and restricted or uncertain immigration statusBriony F Hudson, Elizabeth Dzeng, Angela Burnett, et al.
Neuropharmacology|July 16, 2013
FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal thetaMichelle Yeung, Lily Lu, Adam M Hughes, et al.
Pageof 3